BE Biosol partners Gates Foundation to develop and scale ferric carboxymaltose injection, expanding affordable access to treat iron deficiency anaemia globally. Local authorities and relevant stakeholders are closely monitoring the situation as fresh developments unfold on the ground. Officials noted that further verified updates and administrative measures will be shared following a detailed review.